Telmisartan/Amlodipine Tablets 40/5 mg

Adult dose

The recommended dose for this medication is one tablet once daily, to be taken with water regardless of meals. It is recommended to take it at the same time each day (e.g., in the morning). The 40/5 mg dose is administered to patients whose blood pressure is not adequately controlled with amlodipine 5 mg or telmisartan 40 mg. The 80/5 mg dose is for patients whose blood pressure is inadequately controlled with amlodipine 5 mg or this medication 40/5 mg.

Child dose

The safety and efficacy of this medication in pediatric patients under 18 years have not been established, so its use is not recommended.

This medication should not be used in pregnant women, especially in the second and third trimesters, as it may pose serious risks to the fetus. It should not be administered to patients who are allergic to the active ingredient or similar substances, patients with severe liver impairment or obstructive biliary diseases, severe hypotension, or patients with significantly reduced cardiac function. Patients with primary aldosteronism, certain heart valve diseases, decreased liver function, gastrointestinal diseases, renal vascular diseases, those undergoing dialysis, and the elderly should use this medication with special caution. Various side effects such as dizziness, peripheral edema, headache, dyspepsia, etc. may occur, and if any unusual symptoms appear, consult a healthcare professional immediately. Avoid using this medication during pregnancy, and if pregnancy is confirmed, discontinue use as soon as possible and seek alternative treatment. Since blood pressure may drop too low, if symptoms of hypotension occur at the beginning of treatment, appropriate measures should be taken, and potassium levels and kidney function should be monitored regularly. This medication may interact with other drugs, so inform your doctor or pharmacist of any current medications. It is advisable for breastfeeding women to avoid taking this medication, and it is not recommended for children and adolescents as safety and efficacy have not been sufficiently established. In the case of overdose, symptoms such as hypotension, dizziness, and heart rate changes may occur, so immediate medical attention should be sought. This medication should be kept out of reach of children, stored in its sealed state, and transferred to other containers should be avoided.

Serious side effects

Hives, severe swelling (including angioedema), chest tightness, difficulty breathing, cold sweat, pallor, severe allergic reactions, high fever with severe rash, blisters, skin peeling, mucosal pain in the mouth/eyes, severe skin reactions, shortness of breath or difficulty breathing, asthma attacks, respiratory disorders accompanied by cough and fever, jaundice (yellowing of the skin or eyes), extreme lethargy, liver dysfunction (jaundice).

Mild side effects

Dizziness, peripheral edema, fainting, drowsiness, headache, abnormal sensation, visual disturbances (including double vision), palpitations, flushing, cough, changes in bowel habits (including diarrhea and constipation), abdominal pain, dyspepsia, nausea, vomiting, dry mouth, itching, rash, hair loss, purpura, skin discoloration, sweating, eczema, erythema, thrombocytopenia, anemia, hyperkalemia, hypoglycemia, hyponatremia, hyperglycemia, depression, insomnia, anxiety, confusion, dizziness.

This medication is sensitive to light, so it should be kept in a container that is not exposed to light. Additionally, it is best to store the medication at room temperature between 1 and 30 degrees Celsius to maintain its effectiveness and safety.

Appearance

Biconvex oval double-coated tablet in white and pale blue.

Package unit

30 tablets/box [10 tablets/PTP*3], 30 tablets/bottle, 100 tablets/bottle